MUSC and Bristol-Myers Squibb Announce Translational Research Collaboration
The Medical University of South Carolina and Bristol-Myers Squibb Company (NYSE: BMY) today announced that they have entered into a translational research collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and idiopathic pulmonary fibrosis. The agreement includes studies designed to improve the mechanistic understanding of fibrosis, explore patient segmentation based on disease characteristics and/or […]
